
Biden Administration Announces Additional Steps to Fight COVID-19
This week, the Biden administration unveiled plans to offer booster doses of the Pfizer and Moderna COVID-19 messenger RNA (mRNA) vaccines, pending
Join Us Live for a Discussion on Medicare, Democracy, and the Future of Health Care
Medicare Watch articles are featured in Medicare Rights’ weekly newsletter, which helps readers stay updated on Medicare policy and advocacy developments and learn about changes in Medicare benefits and rules. Subscribe now by visiting www.medicarerights.org/newsletters.

This week, the Biden administration unveiled plans to offer booster doses of the Pfizer and Moderna COVID-19 messenger RNA (mRNA) vaccines, pending

President Biden recently outlined his vision for improving prescription drug affordability. His plan calls on Congress to allow Medicare to negotiate drug prices, impose

This week, Senate Democrats passed their $3.5 trillion budget resolution, laying the groundwork for legislation that is expected to include

The Kaiser Family Foundation (KFF) recently released a report examining Medicare beneficiary access to dental care, including the share of Medicare beneficiaries

Late last month, the Government Accountability Office (GAO), a watchdog agency in the legislative branch, released a report showing that

Medicare is associated with significant reductions in “racial and ethnic disparities in insurance coverage, access to care, and self-reported health,”

Medicare Part D, which covers outpatient prescription drugs for people with Medicare, has four phases of coverage: the deductible, when

This week, Medicare Rights submitted comments on a proposed rule from the Biden administration that would make several important changes

This week, as Congress continued to discuss strategies to improve health coverage, Medicare Rights weighed in, urging them to prioritize critical

New research in JAMA, the Journal of the American Medical Association, reveals that medical debt in the United States before

This week, the Biden administration unveiled plans to offer booster doses of the Pfizer and Moderna COVID-19 messenger RNA (mRNA) vaccines, pending

President Biden recently outlined his vision for improving prescription drug affordability. His plan calls on Congress to allow Medicare to negotiate drug prices, impose

This week, Senate Democrats passed their $3.5 trillion budget resolution, laying the groundwork for legislation that is expected to include

The Kaiser Family Foundation (KFF) recently released a report examining Medicare beneficiary access to dental care, including the share of Medicare beneficiaries

Late last month, the Government Accountability Office (GAO), a watchdog agency in the legislative branch, released a report showing that

Medicare is associated with significant reductions in “racial and ethnic disparities in insurance coverage, access to care, and self-reported health,”

Medicare Part D, which covers outpatient prescription drugs for people with Medicare, has four phases of coverage: the deductible, when

This week, Medicare Rights submitted comments on a proposed rule from the Biden administration that would make several important changes

This week, as Congress continued to discuss strategies to improve health coverage, Medicare Rights weighed in, urging them to prioritize critical

New research in JAMA, the Journal of the American Medical Association, reveals that medical debt in the United States before